NCT06949592View on ClinicalTrials.gov

Oral Bioavailability of the Phenolic Compounds in a Melissa Supplement

NACompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

April 30, 2025

Primary Completion Date

June 12, 2025

Study Completion Date

June 12, 2025

Conditions
Nutrition, Healthy
Interventions
DIETARY_SUPPLEMENT

Placebo

Intake of 400 mg placebo (maltodextrin; encapsulated) in the morning (09:00)

DIETARY_SUPPLEMENT

M_ML

Intake of 400 mg M\_ML (encapsulated) in the morning (09:00)

DIETARY_SUPPLEMENT

M_ML

Intake of 400 mg M\_ML (encapsulated) in the evening (19:00)

Trial Locations (1)

43204

Eurecat, Reus

All Listed Sponsors
lead

Fytexia

INDUSTRY